PharmExec Direct:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
April 4, 2013 | ISSUE NUMBER 294 VOL 10

Global
The Patent Black Label: Six Side-Effects of India’s Novartis Glivec Ruling
Monday’s decision by India’s Supreme Court to deny a patent for the top-selling oncologic drug Glivec took nearly a decade of litigation to resolve — but the implications in and beyond India are both immediate and lasting.  Here’s a list of six that Pharm Exec thinks are most important ...Read more

Cegedim Relationship Management
Webinar: Best Practices for Sunshine Act Compliance
Join King & Spalding and Cegedim Relationship Management to review the new Sunshine Act regulations and their impact on the industry. Discover best practices you can implement to ensure success and achieve efficiency in your Sunshine compliance processes and reporting.   And hear key considerations when choosing or building a solution for aggregate spend and transparency compliance. Register now

Special Report
Pharma in the News: Pharm Exec’s 9th Annual Press Audit
Pharm Exec's ninth annual audit of media coverage of the industry marks a return to the new normal, with scrutiny finely balanced between two polarizing extremes: skepticism about drug safety against the promise of miracle cures stimulated by the billions spent on new medicines research ...Read More

CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
www.bioworld.com

Med Tech
Medication Errors as a Business Opportunity
Ben Comer talks to Mark Sebree, Rx President of med tech company Becton Dickinson, who over the next few years will launch up to 30 generic, pre-filled syringes in an attempt to lower medication errors and raise company revenues
...Read more

New Models of Cancer Research in the Age of Personalized Medicine
Live Webcast: Wednesday, April 17, 2013 at 11:00 am EDT
Register Free at: www.pharmexec.com/personalized

Patient Adherence
The First — and Last — Word on Medication Adherence: Keep Trying!
Patient adherence to medicine is the eternal puzzle for big Pharma, so Pharm Exec believes it’s time to give some expert observers the chance to examine the “state of the art.”  We present a blog geared to helping readers assess the current and future state of medication adherence, in of CBI’s 12th Annual Patient Adherence and Support Summit and Industry Strategic Patient Adherence (SPA) Awards program
...Read more

Marketing
Harnessing the Power of ‘Pull’
It’s not an exaggeration to say that most pharma companies already have hundreds of websites and still more are coming. And now everybody is building apps. That’s a good thing, but there is a problem: how are we planning to get the medical professionals to connect to them?
...Read more

Digital Magazine
Read the April Pharm Exec Global Digest
In the brand new April issue of the Global Digest: The Keys to Personalized Medicine Success; Brand of the Year overview; Is European Healthcare “Failing Patients”?
...Read more

Product Management
The Successful Product Manager’s Handbook
Learn how to create a brand positioning statement, build brand value and turn business information into action. Strategy game planning — a competitive intelligence tool for pharma brand and product managers. Get tips on creating an effective launch plan
...Read more

// FTI Consulting announced that Barbara Ryan, a biopharmaceutical industry expert and member of Pharm Exec’s Editorial Advisory Board, was appointed Managing Director in the firm’s Strategic Communications practice, based in New York. // All Global (New York, NY) announced the appointment of BJ Kirschner as Director, Research Operations, Qualitative. // Independent public health organization NSF International (Ann Arbor, MI) promoted three scientific experts to its executive, health sciences and laboratory teams: Lori Bestervelt, PhD, became Executive Vice President and Chief Technical Officer; Bob Pietrowski, PhD, was promoted to Vice President of NSF’s Global Health Sciences Division; and Kurtis Kneen, PhD, became Vice President of the company’s Global Laboratories.//

April 10–11: Global Transparency Reporting Congress
Brussels, Belgium.


April 29–30: 12th Annual Patient Adherence and Support Summit
Philadelphia, PA.


May 6–7: CBI’s 10th Forum on Patient Reported Outcomes
Philadelphia, PA.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin


Survey
How optimistic are you about your company achieving revenue growth in 2013?

Click To Vote
Quick Links

Are You Still Working on Those Social Media Guidelines?

What’s the FTC’s Beef with Pay-for-Delay?

Patients on the Picket Line